Delaware Street Capital Master Fund, L.P.'s Net Worth
$21.5 Million
Who is Delaware Street Capital Master Fund, L.P.?
Delaware Street Capital Master Fund, L.P. has an estimated net worth of $21.5 Million. This is based on reported shares across multiple companies, which include Neos Therapeutics, Inc., and KEMPHARM, INC.
SEC CIK
Delaware Street Capital Master Fund, L.P.'s CIK is 0001648576
Past Insider Trading and Trends
2017 was Delaware Street Capital Master Fund, L.P.'s most active year for acquiring shares with 3 total transactions. Delaware Street Capital Master Fund, L.P.'s most active month to acquire stocks was the month of August. 2018 saw Delaware Street Capital Master Fund, L.P. paying a total of $7,217,132.00 for 2,304,283 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Neos Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 907.36K |
—
|
—
| 907.36K |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KEMPHARM, INC (ZVRA) Snapshot price: $7.26
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +95.42% | 2M |
$3.00 | $6,000,000.00 | 4.1M |
Oct 5
| |||
Form 4
| +16.98% | 304.28K |
$4.00 | $1,217,132.00 | 2.1M |
Jul 30
| |||
Form 4
| +22.23% | 325.89K |
$3.27 | $1,066,827.43 | 1.79M |
Sep 13 - Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||